Tag Archives: LOGI

Top 5 Warren Buffett Stocks To Invest In 2019

The Kraft Heinz Co. is a $100 billion market capitalization company that generates more than $26 billion in annual revenue by selling iconic brands like Heinz Ketchup, Velveeta Cheese and Kraft Macaroni. Starting in October, Kraft Heinz’s finances will be overseen by a 29-year-old.

The company announced on Friday that David Knopf will be the new chief financial officer of Kraft Heinz. Knopf has been working since 2015 at Kraft Heinz, where his responsibilities included overseeing the Planters Nuts brand and heading global budget and business planning, as well as zero-based budgeting....More>>>

Top 10 Stocks To Watch Right Now

Joindre Capital Services’ research report on Ramco Systems

Ramco Systems Limited (RSL) is a leading cloud-based technology company with global operations. It is engaged in providing Enterprise Resource Planning, Human Capital Management and Aviation Maintenance & Engineering (M&E) & Maintenance Repair & Overhaul (MRO) software to its customers across the globe. RSL is an established player in ERP segment, with a track record of nearly three decades, and catering to a reputed clientele comprising industry majors such as the Danube Group, Emirates, Seagate, Air India....More>>>

Top 10 Tech Stocks To Watch Right Now

After more than a year of bitter rhetoric attacking pharmaceutical companies and the cost of medicines, President Donald Trump is scheduled to finally release his plans to combat drug pricing on Friday.

The near-term implications for biotechnology and pharmaceutical stocks remain murky on Wall Street. Cowen analysts said in a research note Thursday that they expect Trump’s speech will “be relatively benign, with more drastic proposals coming at a later date or not at all.” Wells Fargo & Co.’s David Maris, meanwhile, has cautioned that calls for lower prices....More>>>

Top 10 Undervalued Stocks To Watch Right Now

Research Coverage- Viking Therapeutics (VKTX)

This is meant as a scientific/business development post as to the merits of VKTX. It is well known VKTX is undervalued (by upwards of 40x), but these details will not be discussed here. For a more detailed valuation analysis, see the end of Zacks SCR’s post.

Background

Viking Therapeutics is a clinical stage biopharmaceutical company specializing in metabolic and endocrine disorders. They currently have two clinical assets: VK5211, a selective androgen receptor modulator (SARM) for hip fracture; and VK2809 a thyroid receptor....More>>>